Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Zantac

PharmaCompass

01

Brand Name : Zantac

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Ranitidine Hydrochloride

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 85

2018 Revenue in Millions : 138

Growth (%) : -39

Sanofi Company Banner

02

Brand Name : Zantac

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Ranitidine Hydrochloride

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : -8

2019 Revenue in Millions : 94

Growth (%) : -109

Sanofi Company Banner

03

Brand Name : Zantac

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Ranitidine Hydrochloride

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 144

2017 Revenue in Millions : 132

Growth (%) : 9%

Sanofi Company Banner